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ABSTRACT 48 
Functional recovery after stroke is associated with a remapping of neural circuits. This 49 
reorganization is often associated with low frequency high amplitude oscillations in the peri-50 
infarct zone in both rodents and humans. These oscillations are reminiscent of sleep slow 51 
waves (SW) and suggestive of a role for sleep in brain plasticity that occur during stroke 52 
recovery, however, direct evidence is missing. Using a stroke model in male mice, we 53 
showed that stroke was followed by a transient increase in NREM sleep accompanied by 54 
reduced amplitude and slope of ipsilateral NREM sleep SW. We next used 5 ms optical 55 
activation of Channelrhodopsin 2-expressing pyramidal neurons, or 200 ms silencing of 56 
Archeorhodopsin T-expressing pyramidal neurons, to generate local cortical UP, or DOWN, 57 
states, respectively, both sharing similarities with spontaneous NREM SW in freely-moving 58 
mice. Importantly, we found that single optogenetically-evoked SW (SWopto) in the peri-59 
infarct zone, randomly distributed during sleep, significantly improved fine motor 60 
movements of the limb corresponding to the sensorimotor stroke lesion site, as compared to 61 
spontaneous recovery and control conditions, while motor strength remained unchanged. In 62 
contrast, SWopto during wakefulness had no effect. Furthermore, chronic SWopto during sleep 63 
were associated with local axonal sprouting as revealed by the increase of anatomical pre- 64 
and post-synaptic markers in the peri-infarct zone and corresponding contra-lesional areas to 65 
cortical circuit reorganization during stroke recovery. These results support a role for sleep 66 
SW in cortical circuit plasticity and sensorimotor recovery after stroke and provide a 67 
clinically-relevant framework for rehabilitation strategies using neuromodulation during 68 
sleep. 69 
 70 
 71 
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SIGNIFICANCE STATEMENT 72 
Brain stroke is one of the leading causes of death and major disabilities in elderly worldwide. 73 
A better understanding of the pathophysiological mechanisms underlying spontaneous brain 74 
plasticity after stroke, together with an optimization of rehabilitative strategies, are essential 75 
to improve stroke treatments. Here, we investigate the role of optogenetically-induced sleep 76 
slow waves in an animal model of ischemic stroke and identify sleep as a window for post-77 
stroke intervention that promotes neuroplasticity and facilitates sensorimotor recovery. 78 
79 
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INTRODUCTION 80 
Stroke is an acute brain injury caused by a sudden decrease in cerebral blood flow, followed 81 
by local inflammation (Huang et al., 2006), excitotoxicity (Lai et al., 2014) and cell death 82 
(Small et al., 1999). Changes in neuronal excitability after stroke are thought to promote 83 
long-term plasticity in surviving neurons that contributes to the reorganization of cortical 84 
maps and to the underlying level of axonal sprouting supporting brain functions (Carmichael, 85 
2012; van Meer et al., 2012; Silasi and Murphy, 2014), as observed in rodents (Nudo, 1997; 86 
Murphy and Corbett, 2009; Carmichael et al., 2017) and humans (Khedr et al., 2005; 87 
Lindenberg et al., 2010). To date, pharmacological treatments and non-invasive brain 88 
neuromodulation techniques hold promise in improving plasticity and functional recovery 89 
both in animal model (Zhang et al., 2007; Yoon et al., 2012) and human (Robinson et al., 90 
2008; Ameli et al., 2009; Talelli et al., 2012), yet the underlying mechanisms remain uncler. 91 
 92 
Post-stroke hyperexcitability of surviving neurons contributes to the transient low-frequency 93 
(~ 1 Hz, 200-500 ms in duration), high amplitude, rhythmic waves (also coined ‘bistable 94 
state’) originating in the peri-infarct zone and propagating to contra-lesional brain areas. This 95 
distinctive 1-Hz slow and synchronous neural activity in the peri-infarct zone shares 96 
similarities with slow waves (SW) typically recorded during non-rapid eye movement 97 
(NREM) sleep in rodents and human. Indeed, SW reflect bistable states of thalamocortical 98 
neuron populations, described as a switch between UP states where depolarised membrane 99 
potentials are accompanied by high spiking activity, and DOWN states during which cells are 100 
hyperpolarized and show low spiking activities in cats (Steriade et al., 1993), rodents 101 
(Vyazovskiy et al., 2009; Zucca et al., 2017), non-human primates (Xu et al., 2019) and 102 
human (Csercsa et al., 2010). These SW were hypothesized to guide axonal sprouting and 103 
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circuit rewiring through the formation of new connections after brain lesions (Carmichael and 104 
Chesselet, 2002) facilitating recovery, however this has not been directly demonstrated. 105 
 106 
Extensive experimental evidence suggests a fundamental role for intact sleep, and SW in 107 
particular, in enhancing brain plasticity during spontaneous sleep (Tononi and Cirelli, 2016; 108 
Timofeev and Chauvette, 2017) and stroke recovery (Duss et al., 2017). The detrimental 109 
effects of sleep disturbances (Kaneko et al., 2003; Baglioni et al., 2016) and the beneficial 110 
effect of pharmacological NREM sleep enhancement after stroke support the hypothesis that 111 
SW contribute to brain plasticity underlying post-stroke functional and cognitive recovery 112 
both in animal models (Gao et al., 2008; Hodor et al., 2014) and patients (Vock et al., 2002; 113 
Siccoli et al., 2008; Sarasso et al., 2014). 114 
 115 
Here, we used an optogenetic approach inspired by global and local SW changes after stroke 116 
to rescue SW-like activity in freely-moving mice. Optogenetic activation of pyramidal 117 
neurons in the peri-infarct zone during NREM sleep improved fine motor movements as 118 
compared to experimental control conditions. In contrast, optogenetically-evoked SW 119 
(SWopto) during wakefulness had no effect. Importantly, SWopto evoked recovery after stroke 120 
was associated with axonal sprouting in the peri-infarct zone and corresponding contra-121 
lesional areas. 122 
 123 
 124 
MATERIALS AND METHODS 125 
Animals 126 
C57BL/6JRj male mice (https://www.janvier-labs.com/en/fiche_produit/c57bl-6jrj_mouse/) 127 
(5-6 weeks old, 23-30 grams) were used in the study. Animals were individually housed in 128 
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custom-designed polycarbonate cages (300 mm x 170 mm) under controlled conditions 129 
(regular circadian cycle of 12:12 h light:dark; light on at either 4 a.m. or 8 p.m. according to 130 
experimental design; constant temperature 22 ± 1 °C and humidity 30-50%). Throughout the 131 
experiment animals were freely-moving with ad libitum food and water. Animals were kept 132 
in groups of 2-5 per IVC cage before instrumentation and after viral injection surgery. 133 
Following implantation mice were all housed individually. Animals were tethered, allowed to 134 
adapt to the EEG/EMG and optic stimulation cables in their home cage for at least 5-7 days, 135 
and remained plugged for the duration of the experiment. Animals were detached from all 136 
tethers for 4 days following stroke or sham surgery and for the duration of behavioural 137 
testing. Animals were randomly assigned to eight experimental groups: Channelrhodopsin 138 
(ChR2) transfected animals subjected to stroke (ChR2stroke), ChR2 transfected animals 139 
subjected to stroke and optogenetically stimulated mainly during wakefulness 140 
(ChR2stroke_wake), Archaerhodopsin (ArchT) transfected animals subjected to stroke 141 
(ArchTstroke), mCherry transfected animals subjected to stroke (mCherrystroke), mCherry 142 
transfected animals subjected to sham surgery (mCherrysham), Naive, Sham and Stroke. 143 
Animals that displayed baseline asymmetry in limb usage or did not show a drop in cerebral 144 
blood flow (CBF) by ~ 80% during middle cerebral artery occlusion (MCAo) surgery were 145 
excluded from further experimental tests. Viral injections were performed when animals were 146 
5-6 weeks of age, instrumentation at 8 weeks of age and stroke/ sham surgery at 10 weeks of 147 
age. Between surgeries and before being tethered, animals were let recover undisturbed for at 148 
least 7 days. Naive mice did not undergo any surgical procedures. An additional set of 149 
heterozygous Tg(VGAT-Cre) mice, (5-6 weeks old, 23-30 grams) was used for an 150 
optogenetic screening of slow waves-like oscillations inducing protocols. All animals were 151 
treated according to animal care laws and experimental procedures were approved by local 152 
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authorities (Veterinary Office, Canton of Bern, Switzerland; licence numbers BE 113/13 and 153 
BE 41/17).  154 
 155 
Viral targeting 156 
For a detailed description of the surgical procedure refer to Herrera et al., 2016. Briefly, 5-6 157 
weeks old animals were anesthetized with isoflurane (4.0% induction; 1.0-1.5% 158 
maintenance). Body temperature was constantly monitored and kept at physiological range 159 
using a rectal thermoprobe and feedback-controlled heating system. Animals were fixed in a 160 
digital stereotaxic frame and analgesia was administered subcutaneously (Meloxicam, 161 
5mg/kg). Animals were randomly assigned to receive 0.6 μL of recombinant AAV carrying 162 
either CaMKII-hChR2 (H134)-EYFP (activation), CaMKIIa-eArchT3.0-EYFP (silencing) or 163 
CaMKIIa-mCherry (control) respectively. Plasmids were stereotactically injected (0.1 164 
μL/min infusion rate) through a 28 G needle (Plastic One), connected by a tubing to a 10 μL 165 
Hamilton syringe in an infusion pump (Model 1200, Harvard Apparatus). Injections were 166 
performed within the left (prospective ipsilateral) primary somatosensory forelimb cortex 167 
(iS1FL, AP: -0.10 mm; ML: -2.00 mm; DV: -0.7 mm). Animals were given 7 days of 168 
recovery prior to instrumentation surgery. Tg(VGAT:Cre) mice underwent identical surgical 169 
procedures as wild type animals, randomly assigned to receive 0.6 μL of recombinant AVV 170 
carrying Ef1α-DIO-ChR2-EYFP (activation), Ef1α-DIO-ArchT-EYFP (silencing) or Ef1α-171 
DIO-EYFP (control) respectively. All plasmids were obtained from the University of North 172 
Carolina Vector Core Facility. Mice belonging to Sham, Stroke and Naive groups did not 173 
received any AAV injection.  174 
 175 
Instrumentation 176 
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Animals were chronically implanted with a unilateral optic fiber (200 μm in diameter) within 177 
the iS1FL (AP: -0.10 mm; ML: -2.00 mm; DV: -0.5 mm) and an electroencephalography 178 
(EEG)/electromyography (EMG) connector. As previously reported (Gent et al., 2018), 179 
animals received analgesia (Meloxicam, 5mg/kg), were anaesthetised with isoflurane and 180 
anchored to a stereotaxic frame. Five stainless steel EEG electrode screws were inserted 181 
through each animal’s skull; two screws over the frontal cortices (AP: +2 mm; ML: ±2mm), 182 
two screws over the posterior cortices (AP: -4 mm; ML: ±2 mm) and one screw over the 183 
olfactory bulb as ground. For the stimulation recordings, the EEG signals from the frontal and 184 
posterior channels were referenced to each other directly, leaving only two EEG traces, one 185 
per hemisphere. Finally, two bare-ended EMG wires were sutured to the neck muscles to 186 
record postural tone. A subset of animals was additionally implanted with four tetrodes to 187 
record local field potentials (LFPs) and single unit activity during optogenetic stimulation, as 188 
well as EEG/EMG signals. Tetrodes were constructed by twisting four tungsten wires 189 
together (10 μm in diameter, CFW0010954, California Fine Wire) and briefly heating them 190 
to favour the bond coating of each wire to another. Tetrodes were lowered within the iS1FL 191 
(AP: -0.10 mm; ML: -2.00 mm; DV: -0.5 mm), the ipsilateral primary motor cortex (iM1, 192 
AP: +1.10 mm; ML: -1.5 mm; DV: -1.20 mm), the contralateral S1FL (cS1FL, AP: -0.10 193 
mm; ML: +2.00 mm; DV: -0.5 mm) and the contralateral M1 (cM1, AP: +1.10 mm; ML: 194 
+1.5 mm; DV: -1.20 mm) respectively. The tetrode positioned in iS1FL was glued to the 195 
optic fiber, where the tip of the tetrode extended for ̴ 0.2 mm beyond the end of the fiber 196 
(optrode). Optic fibers and implants were permanently secured to the skull with C&B 197 
Metabond (Patterson Dental) and methacrylate cement (Paladur). Animals were monitored 198 
post-operatively and left to recover undisturbed for at least 7 days. Animals were then 199 
plugged to the EEG/EMG/optic stimulation and tetrodes tethers (Neuralynx headstage). 200 
Black nail polish was applied at the connection point between optic fiber and patch cord to 201 
 
8 
 
limit laser light spreading during optogenetic stimulations. The implantation procedure for 202 
animals belonging to Sham and Stroke groups did not include either optic fiber or tetrodes 203 
placement.  204 
 205 
Transient focal cerebral ischemic stroke 206 
Mice underwent MCAo via intraluminal filament model (Doeppner et al., 2010) at around 10 207 
weeks of age. To begin, mice were anaesthetised with isoflurane as previously described and 208 
placed in a prone position. Physiological temperature was maintained as mentioned above. 209 
The left common carotid artery (CCA) was dissected from the surrounding connective tissue. 210 
A monofilament suture (7-0 silicon rubber coated, coating length 5-6 mm, Doccol 211 
Corporation) was inserted in the CCA and introduced into the lumen of the MCA. The 212 
monofilament was left in place for 45 min to induce both striatal and cortical infarct and 213 
consequently withdrawn to allow the reperfusion of the territory targeted by the MCA. CBF 214 
was constantly monitored by a Laser Doppler probe (Moor Instrument, VMS-LDF2) glued to 215 
the skull above the MCA region. Ischemic stroke induction was considered successful when 216 
the CBF showed a ~ 80 % reduction from baseline values, as well as reperfusion of the MCA 217 
territory. Following surgery, mice were daily checked for pain and weight loss, received 218 
mashed, watered food, subcutaneous analgesia and 0.9% saline. Animals belonging to the 219 
Naive group did not undergo stroke or sham surgery. No filament was inserted into the MCA 220 
during sham surgery. Following MCAo, 40% of animals assigned to the Stroke group and 221 
33% of all animals allocated to optogenetic stimulations did not survive the post-operation 222 
phase. 223 
 224 
Optogenetic stimulation 225 
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Lasers (Laserglow Technologies) attached to the unilateral fiber via patch cord (Thorlabs) 226 
were triggered through TTL with a pulse stimulator (Master - 9, AMPI), this latter controlled 227 
by a function generator (Agilent, 33220A 20MHz Function/ Arbitrary Waveform Generator) 228 
to induce random pulse sequences. Animals received daily 2 h of randomly distributed single 229 
laser light pulses (inter-pulses interval 3-30 sec), from post-stroke day 5 until day 15. The 230 
random distribution of light pulses was selected to avoid hypersynchrony and entrainment of 231 
oscillatory activities which, per se, might influence the observed parameters. The optogenetic 232 
stimulation was semi-chronic: light pulses were distributed across sleep and wake states 233 
without simultaneous behavioural scoring by the experimenter and consequent state specific 234 
stimulation. Indeed, daily and chronic stimulation (11 days) of several animals (experimental 235 
and control were run in parallel) is not suited for a single experimenter. The specific time 236 
allocated for optogenetic intervention was therefore selected according to the natural 237 
distribution of the majority of NREM sleep and wakefulness episodes throughout the 12h 238 
light:dark cycle of the animals. Two stimulation protocols were employed: ChR2-expressing 239 
animals received 5 ms blue light pulses (473 nm wavelength), ArchT-expressing mice were 240 
stimulated with 200 ms green light pulses (532 nm wavelength) and mCherry-expressing 241 
animals were randomly subjected to either 200 ms or 5 ms light pulses. To assess whether the 242 
effect of SWopto on functional recovery was specific to brain activity occurring during sleep, 243 
in a separate group of animals (ChR2stroke_wake) optogenetic stimulations were also delivered 244 
during the first part of the dark phase, when animals were mostly awake. Based on pre-245 
instrumentation testing of both optic fiber and patch cord outputs, light power was set at 20-246 
25 mW. 247 
 248 
Data acquisition 249 
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EEG and EMG signals were amplified (Model 3500, AM System) and digitized at 512 Hz 250 
(NIDAQ 6363, National Instruments) using a sleep recording software (MATLAB written 251 
software, DaqReverse). A 24 h baseline of spontaneous sleep-wake behaviour was recorded 252 
for all animals. Stroke and Sham animals were recorded for 24 h at post-surgery days 1, 3, 5 253 
and 10. All optogenetic stimulations took place between 9 a.m. and 2 p.m., with light on at 4 254 
a.m. for ChR2stroke, ArchTstroke, mCherrystroke and mCherrysham. Since ChR2stroke and 255 
ArchTstroke animals showed similar functional outcomes upon neuronal manipulation during 256 
sleep, an additional ChR2-transfected set of animals received SWopto during animals’ active 257 
phase (between 9 a.m. and 2 p.m., lights on at 8 p.m, ChR2stroke_wake), from post-stroke day 5 258 
until day 15. Animals’ spontaneous sleep was recorded for 18 h at post-stroke day 5, 6, 8, 12 259 
and 14 respectively. LFPs and EEG/EMG signals were amplified and digitized at 32 kHz 260 
(Cheetah 5 acquisition software, Neuralynx, https://neuralynx.com/software/cheetah-5.0-261 
legacy). 262 
 263 
Behavioural tests 264 
All animals were trained in four behavioural tests and engaged in daily training sessions for 265 
three consecutive days. Behavioural baselines were acquired prior to stroke/ sham surgery. 266 
Functional outcomes were verified at post-stroke days 4, 7, 10 and 15. All behavioural tests 267 
were conducted at least 3 h apart from optogenetic stimulations and during animals’ active 268 
phase (between 5 p.m. and 8 p.m.). Test sessions were recorded with a picamera (Raspberry 269 
Pi) and scored in slow motion (VideoPad software, 270 
https://www.nchsoftware.com/videopad/index.html). 271 
Balance beam test: To assess motor balance and coordination (Brooks and Dunnett, 2009) a 272 
round wooden beam (12 mm in diameter, 80 cm long) was positioned at an angle so that one 273 
end of the beam was 60 cm elevated from the working table. At the beam’s elevated end, the 274 
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animal’s home cage served as motivation to complete the task. Soft fabric placed beneath the 275 
beam avoided possible falling injuries. The number of ‘paw faults’ (forelimb or hindlimb 276 
slipping off the beam) were counted during a maximal testing time of 60 sec. Each animal 277 
underwent three trials per time point and means were calculated.  278 
Tight rope test 279 
To measure grip strength and endurance (Balkaya et al., 2013) animals were suspended on a 280 
fine rope (60 cm above the working table) between two platforms (80 cm apart from one 281 
another). Mice were positioned at the middle point of the rope exclusively with their 282 
forepaws. The average time needed to reach one of the two platforms was calculated between 283 
two trials. The maximum testing time was 60 sec. 284 
Corner turn test 285 
To evaluate the presence of unilateral abnormalities (Park et al., 2014) mice where placed in 286 
between two vertical boards forming a 30° angle. Animals left- or right-turn decision was 287 
recorded for a total of 10 trials per testing session. Laterality index was calculated as (number 288 
of left turns – number of right turns)/10. 289 
Ladder walking rig test 290 
The test was chosen to measure paw accurate placement (Cummings et al., 2007). The 291 
apparatus consisted of a ladder (80 cm long), suspended between two platforms (60 cm above 292 
the working table) with randomly spaced rungs. Paw faults were recorded as animals walked 293 
to reach the home cage at one end of the ladder. Mice performances were scored in slow 294 
motion and the mean of three trials calculated. The position of the rungs was randomly 295 
changed across trials to avoid learning. 296 
 297 
Signal processing 298 
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As previously described (Jego et al., 2013), electrophysiological data were manually scored 299 
in 5 sec epochs and analysed using SlipAnalysis (custom written MATLAB program). 300 
Briefly, three vigilance state were identified based on EEG/EMG frequency and amplitude. 301 
Wakefulness was determined by low amplitude EEG and high activity EMG signals; NREM 302 
sleep as high amplitude and low-frequency EEG (0.5-4 Hz) paired with reduced EMG 303 
activity; REM was characterized by theta rhythm (6-9 Hz) EEG and flat EMG. Microarousals 304 
were defined and scored as cortical fast rhythm and EMG bursts of at least 1 sec. Sleep/ 305 
wakefulness scoring was based on the visual characteristics of the contralateral EEG traces 306 
specifically. Electrophysiological analysis was completed using custom MATLAB scripts. 307 
 308 
Automatic single SW detection 309 
Individual SW were detected during NREM sleep epochs during the first 7 h of the lights ON 310 
period in MATLAB using the SWA-MATLAB toolbox (Mensen et al., 2016), with detection 311 
parameters adjusted to rodents from settings described in Panagiotou et al., 2017. Briefly, in a 312 
first-pass of the data, the negative envelope across the 4 EEG channels was calculated, 313 
filtered between 0.5 and 4 Hz (Chebyshev Type II filter design), and consecutive zero-314 
crossings were detected. If the duration between successive downward (negative going) zero-315 
crossing and upward zero-crossing was between 100 msec and 1 sec, then the peak negative 316 
amplitude was examined and was required to be at least 3 deviations from the median 317 
amplitude of all negative peaks in the recording. The amplitude threshold eliminates the 318 
potential individual differences of electrodes reference type, distance to those reference, and 319 
electrode depth that would affect the record amplitude. In a second-pass, the activity over all 320 
4 channels was examined for each slow wave detected on the negative envelope to obtain 321 
individual channel data. 322 
 323 
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Single unit analysis 324 
We performed spike detection and sorting as described previously (Gent et al., 2018). Briefly, 325 
we first extracted multiunit activity from band-pass filtered signals (600-4000 Hz, 4th-order 326 
elliptic filter, 0.1 dB passband ripple, -40 dB stopband attenuation), by applying a detection 327 
threshold of 7.5 × the median of the absolute values of the filtered signal. We then extracted 328 
wavelet coefficients from the detected multiunit activity using a four-level discrete wavelet 329 
transform (Harr wavelet, ‘wavedec’, MATLAB), and subsequently sorted the coefficients 330 
using the super-paramagnetic clustering. We visually inspected the sorted units and excluded 331 
the clusters with a symmetric shape or an average firing rate less than 0.2 Hz from our 332 
analyses. 333 
 334 
Optogenetic response analysis 335 
We assessed the optogenetic response analysis for each vigilance state separately. For unit 336 
activity, we calculated mean firing rates during optogenetic perturbations by averaging firing 337 
rates across trials using a non-overlapping moving window of 5 ms. For LFP analysis, we 338 
averaged raw LFP signals across trials of each vigilance state. 339 
 340 
Infarct volume evaluation and immunohistochemistry 341 
Animals were sacrificed at post-stroke day 15 with 15 mg pentobarbital intraperitoneal 342 
injection (Esconarkon ad us. vet., Streuli Pharma) and transcardially perfused with 1x 343 
phosphate buffered saline (PBS) followed by 4% formalin. Brains were post-fixed overnight, 344 
cryoprotected in 30% sucrose (24-48 h at 4°C), frozen in 2-methyl-butane on dry ice and cut 345 
into 40 μm sections. Every third slice was mounted onto a glass slide, dried at room 346 
temperature (RT), rehydrated and processed for Nissl staining. Briefly, sections were 347 
immersed in Cresyl Violet (Klüver Barrera, Bio-Optica), washed in distilled water and 348 
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dehydrated in graded alcohols, cleared in Xylene (Sigma-Aldrich) and mounted (Eukitt 349 
mounting medium, Bio-Optica) on microscope slides. Stroke edges were delineated per 350 
section using Imagej software (https://imagej.nih.gov/ij/). The damaged area was measured in 351 
each brain slice and multiplied by the distance between brain sections. Stroke volume relative 352 
to the whole brain was calculated as follows: ((volume of contralesional hemisphere - volume 353 
of ipsilesional hemisphere)/2 * volume of contralesional hemisphere) * 100 (Lin et al., 1993). 354 
Fluorescent immunohistochemical staining was performed with free-floating brain sections. 355 
Brain slices were washed in PBS-Triton (PBS-T) and incubated in blocking solution (1 h at 356 
RT; PBS-T with 4% of bovine serum albumin, SIGMA Life Science). Free-floating slices 357 
from ChR2- and ArchT-expressing animals were incubated in a primary antibody to GFP 358 
(chicken IgY fraction anti-GFP, 1:5000, Cat# A10262, RRID:AB_2534023, Life 359 
Technologies) in blocking solution (24-48 h at 4°C). Following repeated washes in PBS-T, 360 
sections were incubated with the secondary antibody (1:500, Cat# ab96947, 361 
RRID:AB_10681017, Abcam) in PBS-T (1 h at RT). Sections were then washed in PBS-T, 362 
mounted and covered on microscope slides. 363 
 364 
Axonal sprouting quantification 365 
Four brains per experimental group were randomly chosen for axonal sprouting evaluation. 366 
Brains were fixed, frozen and cut as previously described. Several 40 μm sections per brain 367 
were selected (approximately, from Bregma 1.10 mm to Bregma -0.70 mm) and stained for 368 
Vglut1, PSD-95 and DAPI. Floating sections were washed in PBS and blocked in PBS with 369 
0.5% Triton X-100 and 10% normal donkey serum (NDS, Jakson ImmunoResearch Code: 370 
017-000-121) (2 h at RT). Sections were then incubated with the following primary 371 
antibodies: chicken IgY fraction anti-GFP (ChR2stroke and ArchTstroke, Cat# A10262, 372 
RRID:AB_2534023, Life Technologies), rabbit anti-Vglut1 (ChR2stroke, ArchTstroke, mCherry-373 
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expressing animals, 1:1000, Cat# 135 303, RRID:AB_887875, SYSY), goat anti-PSD-95 374 
(ChR2stroke, ArchTstroke, mCherry-expressing animals , 1:500, Cat# ab12093, 375 
RRID:AB_298846, Abcam) and mCherry respectively (mCherry-expressing animals, 1:1000, 376 
Cat# M11217, RRID:AB_2536611, Life Technologies) in PBS containing 3% NDS and 377 
0.5% Triton X-100 solution (overnight at 4°C). Brain slices were repeatedly washed in PBS 378 
and incubated with appropriate secondary antibodies (1:500, Alexa Fluor 488 Ab96947, 379 
Abcam; all others 1:1000, Invitrogen) in PBS containing 3% NDS and 0.5% Triton X-100 380 
solution (2 h at RT). A negative control (no addition of primary antibody) was carried out to 381 
confirm the antibody selectivity. Sections were further stained for DAPI (1:500 in PBS, 10 382 
minutes), washed in PBS, mounted on microscope slides and covered. Photomicrographs 383 
were acquired with Olympus Fluoview 1000-BX61 confocal microscope (Olympus, Tokyo) 384 
fitted with 60X oil-immersion objective (4x zoom, 0.5 μm step size). Three fields of interest 385 
(52.172 μm x 52.172 μm) within iS1FL and cS1FLwere imaged in three sections per animal. 386 
Imaris software (Microscopy Image Analysis Software, Bitplane, https://imaris.oxinst.com/) 387 
was used to reconstruct the 3D view of the Z stacks and to evaluate pre- and post- synaptic 388 
compartments’ density and volume. Briefly, background subtraction, image smoothing via 389 
gaussian filtering and channel intensity adjustment were applied and maintained identical for 390 
all the acquired confocal images. A preliminary stack selection was carried out to localize 391 
pucta distributed within two consecutive stacks. A puncta diameter threshold was specified at 392 
0.6 μm and when this value was exceeded, puncta were separated upon visual confirmation 393 
by the experimenter. 394 
 395 
Statistical analysis 396 
For the analyses of the 24 h recordings of stroke and sham animals, a two-level analysis was 397 
performed using linear mixed models. A first-level analysis on each animal and recording 398 
 
16 
 
day, including temporal predictors of recording time, time since last wake epoch in order to 399 
estimate the homeostatic effect on individual slow wave characteristics across the lights on 400 
period as well as the potential differences between the ipsi- and contralateral hemisphere. At 401 
the second level, the parameter estimates from the first level data for each animal for each 402 
day were used to examine the overall effects of stroke over the course of 10 days after stroke. 403 
The potential effects of days, stroke, stimulation group, on sleep parameters and behavioural 404 
outcomes were tested using linear mixed models. Sleep and behavioural values from day 0 405 
was assigned as a baseline predictor, while those from day 4 were used as pre-stimulation 406 
baseline. Main effects and interactions were tested for significance using the log-likelihood 407 
ratio test between the full model and the model without the specific factor in question. The 408 
effects between the stimulation groups were examined by post-hoc t-tests within the linear 409 
mixed model. As an exploratory analysis, macro and micro sleep parameters during the 410 
stimulation time were included as a potential predictor of behavioural outcome: percentage of 411 
NREM, number of micro-arousals, NREM-to-wake transition ratio, wave incidence, wave 412 
amplitude, wave duration, positive and negative slope.  413 
For the pre- and post-synaptic markers assessment, statistical comparisons were determined 414 
with Student’s t-test, one-way ANOVA, where corrections for multiple comparisons were 415 
carried out using Bonferroni correction, if not otherwise indicated (Prism 6 GraphPad; 416 
https://www.graphpad.com/scientific-software/prism/). Data are presented as mean ± standard 417 
error of the mean (s.e.m.) and levels of statistical significance were set at threshold p < 0.05 418 
unless otherwise indicated. Sample sizes were defined based on previous studies (Gao et al., 419 
2008; Jego et al., 2013; Herrera et al., 2016). For each experiment, sample numbers are 420 
indicated in the corresponding figure legends. Animals that did not perform behavioural 421 
testing were excluded from the analysis; as well as mice that lost EEG/EMG signals during 422 
longitudinal measurements. Data distribution was tested for normality using the Lilliefors test 423 
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on the residuals from each linear mixed model calculated and found to be normally 424 
distributed. Experiments were not conducted in blinded fashion. 425 
 426 
Data availability 427 
Dataset and coding supporting the current study are available from the corresponding author 428 
upon request. 429 
 430 
 431 
RESULTS 432 
Stroke alters sleep architecture and SW profile 433 
SWs-like oscillations are frequently observed in peri-infarct zone during NREM sleep and 434 
wakefulness (Yokoyama et al., 1996; Murri et al., 1998; Fernandez-Bouzas et al., 2002). To 435 
refine the characterization of brain activity after stroke, including SW features, we first 436 
quantified the changes of sleep-wake architecture and sleep quality from animals subjected to 437 
MCAo and sham surgeries (Fig. 1A, B). Animals were chronically implanted with 438 
EEG/EMG electrodes for longitudinal sleep recordings prior to, and at 1, 3, 5, and 10 days 439 
after MCAo (see Methods; Fig. 1C). To control for multiple comparisons between the 8 sleep 440 
metrics, the significance threshold was reduced to p < 0.0063 (i.e. 0.05/8; Bonferroni 441 
correction). MCAo resulted in an initial increase of NREM sleep duration with group 442 
differences dampening over the days recorded (Figure 1E, Day by Stroke interaction: LR(1) = 443 
7.977, p = 0.0047). Significant main effects of stroke were found for total wake duration 444 
(Figure 1D; LR(2) = 22.385, p < 0.0001); and wake bout duration (LR(2) = 34.502, p < 445 
0.0001), but this general effect was not significantly different over the days after correction 446 
(Day by Stroke interaction: LR(1) = 4.328, p = 0.0375). No significant results were observed 447 
for REM sleep total duration (Fig. 1F). We further explored the potential effect of stroke size 448 
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within the MCAo group on all sleep architecture measures but found no main effects or 449 
interaction effects with the day of recording (all p-values > 0.0063). 450 
NREM sleep instability, describing the ratio between the animals’ capacity of remaining 451 
asleep compared to waking up, showed that stroke animals were significantly more likely to 452 
wake up (Fig. 1J; LR(2) = 14.918, p = 0.0006). 453 
The number of microarousals, scored as single epoch of 1 sec (minimum) increased EMG 454 
signal within a NREM sleep episode, did not differ between Stroke and Sham (Fig. 1K; 455 
LR(2) = 4.651, p = 0.0977). 456 
 457 
To assess SW features and changes after MCAo stroke, animals were prepared for 458 
simultaneous recordings of EEG/EMG, LFPs or single/ multi-units activities in iS1FL, 459 
cS1FL, iM1 and cM1 layer V (see Methods and Fig. 2B for illustration). Clear periods of 460 
neuronal quiescence corresponding to cortical DOWN states confirmed the selectivity of our 461 
SW detection method (see Methods for detection criteria; Fig. 2A-D). Indeed, perilesional 462 
tetrodes recordings of unit activity in S1FL showed suppression, and subsequent increase, in 463 
neuronal activity (Fig. 2D, top), validating the average unit firing rate observed during the 464 
detected SW (Fig. 2D, bottom). Both local and global SW occurred across all recorded 465 
neocortical areas (Fig. 2A), consistent with previous reports in rodents and humans (Huber et 466 
al., 2004; Vyazovskiy et al., 2011). If individual waves are detected across the 24 h period, 467 
we observed a significant reduction of ipsilateral SW’s amplitude by -13.2 ± 7.3% after 468 
stroke as compared to sham controls that persisted for up to 10 days after stroke (Fig. 2F; day 469 
10: -15.4 ± 6.4%; F(2, 70) = 13.82, p < 0.0001; two-way ANOVA, followed by Bonferroni 470 
post-hoc test). These findings are consistent with hemispheric stroke in rodents and human 471 
subjects (Ahmed et al., 2011; Poryazova et al., 2015). Moreover, the SW positive slope was 472 
reduced within the ipsilateral area of Stroke animals (Fig. 2G; F(2, 76) = 13.02, p < 0.0001), 473 
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whereas the negative slope increased (Fig. 2H; F(2, 76) = 15.89, p < 0.0001). No significant 474 
changes were found in the number of detected SW (Fig. 2I; F(2, 87) = 0.693, p = 0.503) or 475 
their duration (Fig. 2J; F(82, 83) = 0.744, p = 0.478; two-way ANOVA, followed by Tukey 476 
post-hoc test). When exploring for a homeostatic effect, we did not find differences in 477 
amplitude between Stroke and Sham for ipsi- and contralateral EEG traces (LR(2) = 0.940, p 478 
= 0.625) nor for time of night (LR(2) = 3.791, p = 0.150). 479 
 480 
SWopto revealed a critical window of intervention after stroke  481 
Here, we aimed at identifying the effect of optogenetically-induced SW (SWopto) on the 482 
recovery of motor function following MCAo stroke in mice. Thus, we genetically targeted 483 
the expression of opsins to pyramidal neurons in layer V of the neocortex, given their 484 
implication in the generation of slow oscillations (McCormick et al., 2015; Beltramo et al., 485 
2013). To achieve this, we stereotactically infused AAV2 viruses carrying ChR2, ArchT or 486 
mCherry gene cassettes under CaMKII promoter in iS1FL (Fig. 3A, B) before animals were 487 
chronically implanted with EEG/EMG electrodes, tetrodes in cS1FL, iM1 and cM1 cortices 488 
(layer V) and a single optrode in iS1FL (see above and Methods, Fig. 3A). We first optimized 489 
the frequency and duration of optogenetic stimulations to mimic NREM sleep SW in both 490 
wild type and VGAT-Cre transgenic mice to modulate excitatory or inhibitory neurons in 491 
iS1FL with 5 Hz, 1 ms light pulses (activation protocol) or 100, 200, 500 ms single pulses 492 
(silencing protocol) (Fig. 4). We found that 5 ms optogenetic activation of iS1FL ChR2-493 
expressing pyramidal neurons induced a short UP-like state followed by a DOWN-like state, 494 
indistinguishable from spontaneous NREM sleep SW (Fig. 3C-E). Similar SWopto waveform 495 
profiles were obtained upon 200 ms optogenetic silencing of iS1FL ArchT-expressing 496 
pyramidal neurons (Fig. 3F, I). In the latter condition, the duration of the optogenetic 497 
silencing of iS1FL ArchT-expressing pyramidal neurons corresponded to the average 498 
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duration of spontaneous NREM sleep DOWN states (Fig. 2C; duration: 205.2 ± 4.4 ms; Fig. 499 
3H). Off-line analysis confirmed that SWopto duration, negative amplitude and slope were 500 
indistinguishable from naturally occurring NREM sleep SW from the same animal (Fig. 3E, 501 
I). SWopto propagated to contralateral recording sites, where SWopto of variable amplitudes 502 
were recorded in EEG, LFP and single activity traces (Fig. 3D, H and Fig. 5). No changes in 503 
EEG features were observed in control conditions (Fig. 3J-L). 504 
 505 
To determine the optimal window for optogenetic intervention after MCAo, we evaluated the 506 
effect of this stimulation parameters on the survival rates of stroke animals. Strikingly, we 507 
observed that ChR2stroke animals had lower survival rate than ArchTstroke and mCherrystroke 508 
mice when the optogenetic manipulation started on post-stroke day 1 (single 5 or 200 ms 509 
light pulses, at 473 nm or 532 nm, respectively, randomly distributed over 2 h, daily; Fig. 6A; 510 
Chi square(2) = 7.941, p = 0.018; ChR2stroke: 30% survival; ArchTstroke: 75% survival; 511 
mCherrystroke: 77.7% survival; Log-rank Mantel-Cox test), as compared to day 5 (Fig. 6B; 512 
Chi square(4) = 6.383, P = 0.172; ChR2stroke: 60% survival; ArchTstroke: 70% survival; 513 
mCherrystroke: 70% survival; mCherrysham: 100 % survival; Naive: 100 % survival; Long-rank 514 
Mantel-Cox test). These findings are consistent with an increased excitotoxicity after stroke 515 
(Nudo, 2006; Allman et al., 2016), hence, all our optogenetic experiments started on day 5. 516 
 517 
SWopto during sleep improves functional recovery 518 
We next tested whether sleep-specific SWopto improves functional recovery after MCAo in 519 
mice. The expression of ChR2, ArchT and mCherry was genetically targeted to iS1FL 520 
pyramidal neurons as described above (Fig. 3A) before animals were chronically implanted 521 
with a unilateral optic fiber on iS1FL and EEG/EMG electrodes for simultaneous optogenetic 522 
control and polysomnographic recordings in freely moving mice (Fig. 7A; see Methods). 523 
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Sparse SWopto were randomly distributed during sleep starting 5 days after stroke until day 15 524 
(single 5 or 200 ms light pulses, at 473 nm or 532 nm, respectively, randomly distributed 525 
over 2 h, daily; n = ̴ 300 optical stimuli; Fig. 7B, C).  526 
 527 
Evaluation of the animals’ fine motor movements, coordination, strength and asymmetry at 528 
post-stroke day 4 (Fig. 7B) showed severe behavioural deficits in all animals subjected to 529 
MCAo. Indeed, on post-stroke day 4 stroke-induced animals were no longer able to finely 530 
coordinate their grasping movements (Fig. 7D; LR(1) = 27.498, p < 0.0001; Fig. 7F; LR(1) = 531 
32.205, p < 0.0001). As expected, no behavioural impairments were found in mCherrysham 532 
and Naive animals (Fig. 7D; F, respectively, p > 0.05). 533 
In the ladder walking rig test (Fig. 7D), a significant interaction between the stimulation 534 
group and days was found (LR(5) = 11.976, p = 0.035). Post-hoc analysis revealed that the 535 
ArchTstroke group recovered at a faster pace than ChR2stroke_wake (t(101) = 2.842, p = 0.005). 536 
Generally all mice improved across days (LR(6) = 28.235, p < 0.001). Main effects of 537 
stimulation group were also found (LR(10) = 42.949, p < 0.001). ChR2stroke, ChR2stroke_wake 538 
were significantly different from mCherrystroke (t(101) = -2.430, p = 0.017; t(101) = -3.137, p 539 
= 0.002). For the beam balance (Fig. 7F) we found a significant interaction effect of 540 
stimulation group and day (LR(5) = 14.171, p = 0.015). mCherrystroke did not show a 541 
significant improvement across days (t(152) = -1.671, p = 0.097). However, compared to 542 
mCherrystroke, Archtstroke mice showed significantly more improvement over the course of 543 
days (t(110) = -2.866, p = 0.005). ChR2stroke mice also significantly improved across days 544 
after stroke (t(152) = -4,168, p < 0.001), but this improvement was less than the ArchTstroke 545 
group (t(110) = -2.285, p = 0.024) and on par with the mCherrystroke group (t(110) = 0.580, p 546 
= 0.563). Comparisons of animal improvement between post-stroke day 4 and 15 confirmed 547 
the functional recovery of ChR2stroke (Fig. 7E; t(14) = 3.46, p = 0.007; Fig. 7G; t(18) = 2.372, 548 
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p = 0.029) and ArchTstroke (Fig. 7E; t(14) = 3.083, p = 0.008; Fig. 7G; t(18) = 3.895 p = 549 
0.002; one-way ANOVA), in comparison to mCherrystroke control. In contrast, optogenetic 550 
intervention after stroke did not lead to any improvement of motor endurance, strength (Fig. 551 
7H) or asymmetry (Fig. 7I). 552 
 553 
SWopto increases axonal sprouting 554 
Stroke triggers a cascade of molecular and cellular changes including synaptogenesis, 555 
neurogenesis and axonal sprouting in peri-infarct zone and remote connected circuits (Nudo, 556 
1997; Carmichael et al., 2017). 557 
To quantify the anatomical changes induced by chronic SWopto, we quantified the expression 558 
of pre-synaptic Vglut1 and post-synaptic PSD-95 proteins as a direct measurement of axonal 559 
sprouting in cortical layers V (Liu et al., 2007; Sun et al., 2017) and connected circuits in 560 
layers II (Binzegger et al., 2004; Adesnik and Naka, 2018) (Fig. 8A). Puncta density 561 
quantification in both iS1FL and cS1FL cortices revealed a significantly higher Vglut1 562 
protein levels in ipsilateral layer II (Fig. 8B; F(3, 19) = 10.49, p = 0.0003), and layer V (Fig. 563 
8C; F(3,18) = 16.02, p > 0.0001; one-way ANOVA) from ChR2stroke and ArchTstroke animals, 564 
as compared to mCherry controls. Consistently, analysis of Vglut1 positive puncta volume 565 
distribution revealed a significant increase of smaller, newly-formed puncta within ipsilateral 566 
layer V of both ArchTstroke and ChR2stroke as compared to mCherrystroke animals (Fig. 8E; F(2, 567 
2111) = 75.13, p < 0.0001). This was also true for ex novo Vglut1 puncta in post-synaptic 568 
sites of layer II from ChR2stroke animals (Fig. 8D; mCherrystroke vs. ChR2stroke t(2070) = 4.181, 569 
p < 0.0001), but not ArchTstroke animals (mCherrystroke vs. ArchTstroke t(2070) = 3.015, p = 570 
0.0078, ChR2stroke vs. ArchTstroke t(2070) = 0.903, p > 0.999; one-way ANOVA, followed by 571 
Bonferroni correction).  572 
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These pre-synaptic changes were concomitant to a significant decrease of post-synaptic PSD-573 
95 protein expression in iS1FL layer II of both ChR2 and ArchT expressing animals when 574 
compared to control group (Fig. 8F; F(3, 23) = 8.609, p = 0.0005; one-way ANOVA), with 575 
no differences in layer V (Fig. 8G; F(3, 24) = 1.095, p = 0.370; one-way ANOVA). PSD-95 576 
positive puncta volume were significantly larger iS1FL layer II (Fig. 8H; F(2, 625) = 85, p < 577 
0.0001) and layer V from ChR2stroke animal as compared to mCherrystroke or ArchTstroke (Fig. 578 
8I; (F(2, 2111) = 75.13), p < 0.0001; one-way ANOVA). 579 
 580 
 581 
DISCUSSION 582 
Stroke is a debilitating neurological disorder and one of the worldwide leading causes of 583 
adult disability and death in aging population. A better understanding of the complex 584 
pathophysiological mechanisms underlying the stroke event and the following brain plasticity 585 
warrants the improvement of existing strategies and the development of alternative therapies 586 
for stroke recovery (Feigin et al., 2017).  587 
Here, we showed that MCAo induced an ipsilateral reduction of spontaneous SW amplitude, 588 
associated with sleep fragmentation and increased NREM sleep after stroke onset (Giubilei et 589 
al., 1992; Vock et al., 2002; Baumann et al., 2006; Hermann et al., 2008). Our results further 590 
indicate that sleep-specific optogenetic neuromodulation of brain activity after stroke had no 591 
effects on the sleep-wake cycle architecture, but it improved fine skilled motor movements in 592 
comparison to wakefulness interventions. These manipulations were accompanied by axonal 593 
sprouting of local and connected circuits, suggesting a direct role for SW in promoting 594 
anatomical and functional plasticity of neural circuit during sleep (Carmichael and Chesselet, 595 
2002; Aeschbach et al., 2008; Tononi and Cirelli, 2014). Collectively, these findings 596 
emphasize a role for NREM sleep SW as a window of intervention during stroke recovery 597 
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and a possible mechanism underlying the improvement of rehabilitative strategies using 598 
repetitive transcranial magnetic stimulation (rTMS) (Kim et al., 2006; Brodie et al., 2014) 599 
and transcranial direct current stimulation (tDCS) (Boggio et al., 2006; Lindenberg et al., 600 
2010).  601 
 602 
Spontaneous sleep SW are associated with neuroplastic changes (Tononi and Cirelli, 2006; 603 
Puentes-Mestril and Aton, 2017), inflammatory and immunological adaptative response 604 
(Irwin and Cole, 2011), protective functions during infection (Irwin, 2019), metabolic 605 
clearance (Xie et al., 2013). Clinical studies reported significant improvement in stroke 606 
rehabilitation upon non-invasive brain stimulation during sleep (Niimi et al., 2018) and SW 607 
enhancement (Ebajemito et al., 2016). We used physiologically-relevant stimulation 608 
protocols to avoid neuronal hypersynchrony, un-natural firing activities and circuit adaptation 609 
by using single optogenetic stimuli randomly distributed across sleep in freely-moving 610 
animals. These sparse optogenetics interventions induced SWopto without perturbing sleep-611 
wake cycle architecture. Our strategy contrasts from other studies that use long-lasting 612 
hypersynchronous optogenetic activation independently of the animal behaviour, sleep-wake 613 
states, or delivered during anaesthesia (Cheng et al., 2014; Shah et al., 2017; Tennant et al., 614 
2017; Lu et al., 2017). Our findings show that sparse SWopto delivered during sleep improved 615 
behavioural outcomes whereas SWopto during wakefulness did not. An explanation for this 616 
striking difference is that low frequency, high amplitude waves during wakefulness represent 617 
dysfunctional waves, typical of pathological conditions that are often associated with 618 
functional abnormalities, including deafferentiated or lesioned thalamo-cortical circuits 619 
(Steriade et al., 1993; Butz et al., 2004). These results further emphasize the importance of 620 
sleep as a window for optimal modulation of brain activity that potentiates the effect of 621 
SWopto on brain plasticity and behavioural outcomes (see below).  622 
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 623 
Alteration of sleep-wake cycle and slow wave 624 
Our findings showed that stroke injury induces a dramatic increase in NREM sleep on the 625 
day following stroke. This effect is accompanied by transient perturbation of the circadian 626 
sleep distribution across the light/ dark cycle. Although the causes of these transient changes 627 
remain unclear, they may result from a functional adaptation to the strong fragmentation of 628 
both NREM sleep and wakefulness.  629 
Our experimental results are consistent with the sleep fragmentation, the increase in NREM 630 
sleep stages 1-2 and the decreased REM sleep observed during the first days following stroke 631 
in human (Giubilei et al., 1992; Vock et al., 2002). Sleep fragmentation may result from a 632 
lack of consolidated synchrony of neuronal activity amongst thalamo-cortical circuitries, as 633 
suggested by the decreased amplitude and positive slope of spontaneous SW after stroke 634 
observed in our study. These SW profiles are indicative of low spiking synchrony of thalamic 635 
and cortical neurons (Huber et al., 2004; Vyazovskiy et al., 2009), which may facilitate 636 
arousal upon wake-promoting inputs of sub-cortical origins (Adamantidis et al., 2007; Carter 637 
et al., 2010; Herrera et al., 2016; Gent et al., 2018). Whether the SW remaining after stroke 638 
are generated by a similar mechanism and support similar cortical functions, as the 639 
naturalistic SW recorded from an intact brain remains to be examined in light of the different 640 
cells types potentially implicated in SW generation (Gerashchenko et al., 2008; Cardin et al., 641 
2009; Stroh et al., 2013; Jackson et al., 2016; Niethard et al., 2016). An important 642 
characteristic of spontaneous sleep SW is their propagation pattern across the brain cortex, 643 
originating at anterior regions and travelling to posterior directions (Massimini et al., 2004, 644 
Gent et al., 2018). Investigating SW’s traveling changes across the ipsi-lateral hemisphere 645 
and the peri-infarct zone specifically represents an interesting additional aspect to explore in 646 
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future work. The experimental preparation of the present study (single EEG trace per 647 
hemisphere) limited further SW analysis in this direction. 648 
 649 
SWopto promotes behavioural recovery after stroke 650 
Chronic SWopto over 11 days after stroke facilitated spontaneous functional recovery, while 651 
earlier interventions exacerbated brain injury and decreased the survival rate of the animals, 652 
possibly due to excessive glutamate release (Lai et al., 2014) leading to increased 653 
excitotoxicity (Nudo, 2006; Allman et al., 2016). This window of spontaneous recovery is 654 
limited to a month in rodents, and three months in humans, during which molecular and 655 
structural changes potentiate the responsiveness to rehabilitative treatments (Murphy and 656 
Corbett, 2009; Ng et al., 2015) and emphasize a crucial intervention timeframe (Dromerick et 657 
al., 2009). Although post-stroke excitotoxicity might be an accurate explanation for the 658 
detrimental effect observed in animals’ survival, additional studies are required to further 659 
scrutinize markers of excitotoxicity (e.g. levels of glutamate, NMDA receptors, AMPA 660 
receptors and their activation, caspases, reactive oxygen species) in combination with 661 
optogenetic intervention at several time points following stroke.  662 
 663 
An interesting finding in our study is that SWopto had no direct effects on sleep architecture 664 
but induced a delayed increase of sleep duration. This result is in agreement with studies 665 
showing prolonged NREM sleep upon activation of somatostatin interneurons (Funk et al., 666 
2017), and to a lesser extent pyramidal neurons (Rodriguez et al., 2016) in the neocortex. 667 
Noteworthy, increased NREM sleep following SWopto intervention was present only within 668 
the first two days of stimulation (not shown), presumably due to the brain recovery processes 669 
or the adaptation of the sleep-promoting circuits to the SWopto, or both. Although we cannot 670 
rule out a possible role of this transient NREM sleep increase on the sensorimotor 671 
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improvement of the animals, it is unlikely that these early and transient changes are 672 
responsible for the motor improvements observed at the end of the experiment. 673 
 674 
Slow wave, plasticity and axonal sprouting 675 
In our experiments, sensorimotor improvement after stroke was achieved by either chronic 676 
optogenetic activation, or silencing, of iS1FL pyramidal neurons in freely-moving mice, 677 
supporting an essential role for UP-DOWN states, rather than neuronal activation or silencing 678 
alone, in brain plasticity (Puentes-Mestril and Aton, 2017). These bistable states during 679 
NREM sleep (here, mainly SWopto) are associated with synaptic plasticity in local circuits and 680 
their postsynaptic targets, as observed for the beneficial effect of sleep low frequency 681 
stimulation of motor or somatosensory cortical circuits on perceptual learning (Miyamoto et 682 
al., 2016) or the formation of new dendritic spines in motor cortex (layer V) pyramidal 683 
neurons in mice (Yang et al., 2014). Furthermore, our results are in agreement with the 684 
finding that experimental disruption of cortical SW following learning impairs consolidation 685 
of visuomotor learning in human (Landsness et al., 2009).  686 
 687 
The early stages of stroke recovery are classically attributed to brain oedema resorption and 688 
penumbra reperfusion, while later stages are associated with structural reorganization through 689 
axonal sprouting, synaptogenesis and neurogenesis (Nudo, 2006). Here, both ChR2-, and to a 690 
lesser extent ArchT-induced SWopto promoted an increase of pre- and post-synaptic markers 691 
in S1FL layers V and II respectively. Decreased PSD-95 density after SWopto is consistent 692 
with similar findings upon rTMS stimulation in rodents (Etiévant et al., 2015) that correlate 693 
with improved functional outcomes in non-human primates treated with PSD-95 inhibitors 694 
(Cook et al., 2012). Larger PSD-95 puncta were found within both layers II and V of 695 
ChR2stroke animals, suggestive of a stabilization of the functional synapse (Cane et al., 2014). 696 
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Thus, SWopto enhance UP/ DOWN state network synchronization (Gent et al., 2018) and 697 
facilitate the formation of new synapses which are not restricted to targeted cortical circuits 698 
(i.e. pyramidal neurons in the peri-infarct zone) but also anatomically connected circuits 699 
located in ipsi- and contra-lateral hemispheres (Liu et al., 2009; Cui et al., 2013). 700 
Noteworthy, brain activity in other cortical and sub-cortical networks and other sleep 701 
oscillations including spindles participate to synaptic plasticity during NREM sleep 702 
(Rosanova and Ulrich, 2005; Chauvette et al., 2012) and may contribute to the behavioral 703 
outcome reported here. 704 
 705 
Collectively, our findings support a role for NREM sleep SW in neuronal circuit plasticity 706 
and provide a clinically-relevant framework for developing sparse, non-invasive 707 
neuromodulation, including acoustic brain stimulations (Ngo et al., 2013), TMS or tDCS 708 
(Ebajemito et al., 2016; Niimi et al., 2018) for optimal recovery after brain injury. 709 
710 
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FIGURE LEGENDS 996 
 997 
Figure 1. Stroke alters sleep architecture. (A) Schematic of the Circle of Willis (CW) with 998 
highlighted common carotid artery (CCA), internal carotid artery (ICA), middle cerebral 999 
artery (MCA) involved in MCAo procedure and filament placement. (B) Coronal sections (40 1000 
μm) of a representative mouse 15 days after MCAo. Nissl staining. (C) Schematic 1001 
representation of EEG and EMG electrodes placements relative to stroke. 24 h recordings of 1002 
animals’ sleep-wake cycles were performed before stroke (Baseline) and again at post-stroke 1003 
day 1, 3, 5 and 10 in Stroke (n = 11) and Sham (n = 9) animals. (D) Percentage changes of 1004 
wakefulness, NREM sleep (E) and REM sleep (F) total durations from each animal’s baseline 1005 
values. (G) Comparison between bout durations of wakefulness, NREM sleep (H) and REM 1006 
sleep (I). (J) Ratio between NREM continuous episodes and transitions to wake. (K) Total 1007 
number of microarousals in 24 h recordings. (L) Percentage of epochs spent in wake or sleep 1008 
states for Stroke (blue table) and Sham (grey table) groups, respectively. Linear mixed model 1009 
of 8 matrices: Wake duration changes; NREM duration changes; REM duration changes; 1010 
Wake bout duration; NREM bout duration; REM bout duration; NREM stability; 1011 
Microarousals. Data are represented as means ± s.e.m.; asterisks indicate significance *p < 1012 
0.0063. 1013 
 1014 
Figure 2. Stroke alters SW profile. (A) Automatic detection of single slow waves (SW) from 1015 
local field potential (LFP) recordings in ipsilateral primary somatosensory forelimb cortex 1016 
(iS1FL), ipsilateral primary motor cortex (iM1), contralateral M1 (cM1), contralateral S1FL 1017 
(cS1FL) and EEG traces from ipsilateral (iEEG) and contralateral (cEEG) hemispheres. 1018 
Representative traces in black and detected SW in colours (top). Magnification of one 1019 
episode of NREM sleep and detected SW (bottom). (B) Schematic of tetrodes and EEG/EMG 1020 
electrode implantation. (C) Representative average SW from 24 h baseline EEG recording. 1021 
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(D) Unit activity heat map of neurons recorded during detected SW; the graph shows 1022 
neuronal activity suppression corresponding to the silent SW DOWN state (top). Average 1023 
firing rate of single units recorded during the detected SW (bottom). (E) Schematic of EEG 1024 
electrodes position. (F) SW peak to peak amplitude prior to (Baseline) and following MCAo 1025 
or sham surgery (post stroke day 1, 3, 5 and 10). (G) SW positive slope. (H) SW negative 1026 
slope. (I) Number of single SW detected. (J) SW duration. Stroke n = 11, Sham n = 9; two-1027 
way ANOVA, followed by Bonferroni post-hoc test. Data are represented as means ± s.e.m. 1028 
Asterisks indicate significance *p < 0.05. 1029 
 1030 
Figure 3. Optogenetic induction of SW-like bistable oscillations. (A) Scheme of a coronal 1031 
brain section with AAV injection site (left), AAV structure (top) and optrode/EEG/EMG 1032 
implantation representation (right). (B) Opsin distribution within the peri-infarct ipsilateral 1033 
primary somatosensory forelimb cortex (iS1FL) following AAV injection of CaMKII-ChR2-1034 
EYFP. (C) Local field potential (LFP) traces, single unit activity and correspondent raster 1035 
plot and mean spike rate upon optogenetic stimulation during wakefulness (left), NREM 1036 
sleep (middle) and REM sleep (right) from one representative stimulation session. (D) 1037 
Average ipsilateral (iEEG) and contralateral EEG (cEEG) traces response to activation 1038 
(ChR2) of pyramidal neurons with 5 ms of single laser light pulses (473 nm). (E) Comparison 1039 
between spontaneous and optogenetically-evoked SW (SWopto) duration (left), negative 1040 
amplitude (middle) and slope (right) during NREM sleep for ChR2 stimulated animals; 1041 
Wilcoxon rank sum test, statistically significant if p < 0.05. (F) ArchT distribution within 1042 
iS1FL. (G) Representative EEG/EMG traces upon silencing of pyramidal neurons with 200 1043 
ms of single laser light pulses (532 nm) during NREM sleep. (H) Average iEEG and cEEG 1044 
responses to ArchT stimulation. (I) Comparison between SWopto duration (left), negative 1045 
amplitude (middle) and slope (right) during NREM sleep for ArchT stimulated animals; 1046 
 
43 
 
Wilcoxon rank sum test, statistically significant if p < 0.05. (J) mCherry (control) expression 1047 
in iS1FL; representative EEG/EMG responses during 5ms light pulse stimulation (top) and 1048 
average EEGs (bottom). (L) Representative EEG/EMG traces response to 200ms pulse 1049 
stimulation in one mCherry transfected mouse (top) and its average EEGs response. 1050 
 1051 
Figure 4. Optogenetic screening for slow waves induction in the peri-infarct zone. (A) 1052 
Coronal section indicating the AAV injection site (left primary somatosensory forelimb 1053 
cortex, S1FL) (top) and schematic of EEG/EMG/optic fiber/tetrodes implantation (bottom). 1054 
(B) LFP recordings from S1FL upon laser light stimulation (500 ms, 5 Hz and 200 ms) of 1055 
inhibitory (top) or pyramidal neurons (bottom) respectively.  1056 
 1057 
Figure 5. SWopto oscillations travel across hemispheres. (A) Local field potential (LFP) 1058 
traces, multi-unit activity from tetrodes placed in ipsilateral primary somatosensory forelimb 1059 
cortex (iS1FL), contralateral S1FL (cS1FL), ipsilateral primary motor cortex (iM1) and 1060 
contralateral M1 (cM1) and EEG/EMG traces recorded during one stimulating session 1061 
showing the travelling characteristic of the evoked waves (SWopto). (B) Raster plots 1062 
corresponding to one single light pulse stimulation event during wakefulness, NREM and 1063 
REM sleep as well as relative mean spike rate for iS1FL, cS1FL, cM1 respectively. No unit 1064 
was found for iM1. (C) Average LFP traces during the stimulation events for the four 1065 
recorded cortical areas respectively. 1066 
 1067 
Figure 6. SWopto defines a critical window of intervention for stroke recovery. (A) When the 1068 
stimulation protocol started at post-stroke day 1, ChR2stroke animals in particular showed 1069 
lower survival percentage. (B) When the stimulation instead began at post-stroke day 5, 1070 
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ChR2stroke animal showed an improvement in survival percentage. Asterisks indicate 1071 
significance *p < 0.05. 1072 
 1073 
Figure 7. SWopto during sleep improves functional recovery after stroke. (A) Schematics of 1074 
optic fiber/EEG/EMG implantation with opsin expression site. (B) Experimental timeline. (C) 1075 
Average number of single light pulses within sleep stages during the stimulation sessions of 1076 
ArchTstroke, ChR2stroke, mCherrystroke, mCherrysham and ChR2stroke_wake respectively. (D) 1077 
Stimulated animals showed better performances in the ladder walking rig test compared to 1078 
mCherry-control animals (Naive n = 8, mCherrysham n = 8, ArchTstroke n = 4, ChR2stroke n = 7, 1079 
mCherrystroke n = 6). Induction of slow waves mainly during wakefulness (ChR2stroke_wake n = 1080 
6) did not result in faster improvement of performance compared to ChR2stroke stimulated 1081 
during NREM sleep. Linear mixed model. (E) Percentage of improvement from post-stroke 1082 
day 4 to post-stroke day 15 for ChR2stroke groups and ArchTstroke compared to mCherrystroke 1083 
control (one-way ANOVA). (F) Similar results was observed for performances in the balance 1084 
test (Naive n = 8, mCherrysham n = 6, ArchTstroke n = 7, ChR2stroke n = 7, mCherrystroke n = 7, 1085 
ChR2stroke_wake n = 6). (G) Balance beam percentage of improvement from post-stroke day 4 1086 
to post-stroke day 15 for ChR2stroke groups and ArchTstroke compared to mCherrystroke control 1087 
(one-way ANOVA). (H) Tight rope test and corner test (I) did not show differences between 1088 
stimulated and control groups (Naive n = 8, mCherrysham n = 6, ArchTstroke n = 7, ChR2stroke n 1089 
= 6, mCherrystroke n = 8, ChR2stroke_wake n = 6). Asterisks indicate significances *p < 0.05. 1090 
 1091 
Figure 8. SWopto increases axonal sprouting during stroke recovery. (A) Scheme of a brain 1092 
coronal section 15 days after stroke (end point of experiment) representing tissue atrophy 1093 
corresponding to the stroke area. Confocal micrography of iS1FL with 3D reconstruction of 1094 
pre- and post-synaptic markers contact (right). Blue: DAPI staining; red: Vglut1 pre-synaptic 1095 
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marker; acquamarine: PSD-95 post-synaptic marker. (B) Comparison of Vglut1 puncta 1096 
density between iS1FL and cS1FL cortical areas (mCherrystroke n = 4, ChR2stroke n = 4, 1097 
ArchTstroke n = 4, mCherrysham n = 4) in ipsilateral (F (3, 19) = 10.49, p = 0.0003) and 1098 
contralateral layers II (F (3, 19) = 1.069, p = 0.385), as well as in ipsilateral (F (3, 18) = 1099 
16.02, p < 0.0001) and contralateral layers V (F (3, 21) = 11.05, p = 0.0001) (C). (D) Vglut1 1100 
puncta volume distribution in iS1FL layer II (F (2, 1630) = 34.85, p < 0.0001) and layer V 1101 
(E) summarized in bar graph (F (2, 1617) = 155, p < 0.0001). (F) Comparison of PSD-95 1102 
puncta density in ipsilateral (F (3, 23) = 8.609, p = 0.0005) and contralateral (F (3, 21) = 1103 
1.105, p = 0.369) layers II, as well as in ipsilateral (F (3, 24) = 1.095, p = 0.370) and 1104 
contralateral (F (3, 24) = 2.498, p = 0.083) layers V (G). (H) PSD-95 puncta volume 1105 
distribution in iS1FL layer II summarized in bar graph (F (2, 2070) = 9.164, p = 0.0001); (I) 1106 
iS1FL layer V (F (2, 2111) = 75.13, p < 0.0001). One way-ANOVA. Data are represented as 1107 
means ± s.e.m. Asterisks indicate significance *p < 0.05. n.s. = not significant. 1108 








